Several enzymes involved in the KYN pathway, including indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO2), are upregulated in cancer cells and contribute to therapy resistance. This evidence concerns the gene TDO2 and cancer.